BioCentury
ARTICLE | Company News

Peptinnovate, MRC deal

July 27, 2015 7:00 AM UTC

Peptinnovate and MRC partnered to evaluate the therapeutic potential of Pepinnovate’s peptides, which are derived from Mycobacterium tuberculosis, to treat bone diseases. The peptides will tested at M...